POU5F1P4: A Potential Drug Target and Biomarker (G645682)

Target Name: POU5F1P4

NCBI ID: G645682

POU5F1P4

Other Name(s): Oct-3 | OTF-3 | OCT3 | Oct4-pg4 | POU class 5 homeobox 1 pseudogene 4 | POU5F1 | POU5FLC1 | OTF3 | Oct-4 | OCT4

POU5F1P4: A Potential Drug Target and Biomarker

POU5F1P4, also known as POU5F1-like protein 4, is a gene that encodes a protein located in the endoplasmic reticulum (ER) of eukaryotic cells. The ER is a organelle responsible for the synthesis, storage, and degradation of proteins, and it is a critical platform for the regulation of protein function. POU5F1P4 is expressed in most tissues and cells, and it has been implicated in various cellular processes, including protein synthesis, degradation, and modulation.

The protein encoded by POU5F1P4 is a 21-kDa protein that contains 115 amino acid residues. It belongs to the POU5F1 gene family, which is characterized by similar proteins that share a conserved catalytic domain and a common structure. POU5F1P4 is expressed in most tissues and cells and has been shown to be involved in various cellular processes, including cell signaling, protein synthesis, and degradation.

One of the key functions of POU5F1P4 is its role in protein synthesis. POU5F1P4 is a key protein of the heat shock protein (HSP) family, which is involved in the regulation of protein stability and dynamics. HSPs are highly conserved proteins that can form a complex with other proteins to ensure their stability and to facilitate their transport and degradation. POU5F1P4 is one of the best-known HSPs, and its function in protein synthesis has been studied extensively.

In addition to its role in protein synthesis, POU5F1P4 is also involved in the regulation of protein degradation. POU5F1P4 has been shown to play a role in the degradation of various proteins, including heat shock proteins (HSPs) themselves. This is important for maintaining the homeostasis of the cell, as the degradation of proteins is critical for maintaining the balance of intracellular and extracellular components.

POU5F1P4 has also been shown to be involved in cell signaling. POU5F1P4 is a potential signaling molecule that can interact with various signaling pathways. For example, POU5F1P4 has been shown to interact with the protein kinase A, which is involved in cell signaling. This interaction between POU5F1P4 and A is important for the regulation of various cellular processes, including cell growth, differentiation, and survival.

Furthermore, POU5F1P4 is also involved in the regulation of protein synthesis and degradation in response to various environmental conditions, such as changes in temperature, pH, and concentration of nutrients. This is important for maintaining the stability of the cell and for responding to external stimuli.

In conclusion, POU5F1P4 is a gene that encodes a protein that is involved in various cellular processes, including protein synthesis, degradation, and signaling. Its function in these processes is critical for maintaining the homeostasis of the cell and for responding to external stimuli. Therefore, POU5F1P4 is a potential drug target and biomarker for various diseases, including neurodegenerative disorders, cancer, and cardiovascular diseases. Further research is needed to fully understand the role of POU5F1P4 in these processes and to develop effective treatments.

Protein Name: POU Class 5 Homeobox 1 Pseudogene 4

The "POU5F1P4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POU5F1P4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets